润本股份2025年年度权益分派实施公告深度解读
一、公告要点概览
润本生物技术股份有限公司（证券代码：603193，证券简称：润本股份）于2026年5月25日发布了2025年年度权益分派实施公告。此次权益分派将为公司股东带来可观的现金红利，具体实施细则及相关税务政策对投资者具有重要参考价值。
二、分红方案详情
- 每股分红：本次分红以2026年5月28日下午收市后公司总股本404,593,314股为基数，每股派发现金红利0.26元（含税），总代发放金额为105,194,261.64元（含税）。
- 差异化分红送转：本次分红不涉及差异化分红送转。
三、关键日期安排
| 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 |
|---|---|---|---|---|
| A股 | 2026/5/28 | – | 2026/5/29 | 2026/5/29 |
四、权益分派实施与领取办法
- 无限售条件流通股红利将委托中国结算上海分公司，通过资金清算系统向登记在册股东派发。
- 已办理指定交易的投资者可在红利发放日于指定证券营业部领取现金红利，未办理指定交易的投资者需补办手续后领取。
- 部分大股东将由公司自行发放红利，包括广州卓凡投资控股有限公司、赵贵钦等。
五、税务政策详解（对投资者极为重要）
- 自然人股东及证券投资基金：
- 持股超1年：股息红利所得暂免征收个人所得税，实际每股派发0.26元。
- 持股1年及以内：暂不扣税，实际派发0.26元，转让时由券商代扣代缴，持股1个月以内税率20%，1个月-1年10%。
- 有限售条件流通股自然人及基金：解禁前分红实际税负10%，税后每股0.234元，解禁后按持股时间再计算。
- QFII/RQFII：代扣代缴10%，实际每股0.234元。若享受税收协定，可自行申请退税。
- 沪港通投资者：公司代扣10%税后，每股0.234元。
- 其他机构投资者和法人股东：公司不代扣代缴，需自行申报纳税，实际派发为税前每股0.26元。
税务政策的差异将直接影响投资回报，建议投资者根据自身身份及持股情况及时关注税务申报与扣缴事宜。
六、减持价格承诺调整（高度敏感信息）
- 公司实际控制人、董事、高级管理人员及控股股东此前承诺：首发前持股锁定期满后两年内减持价格不得低于发行价。若期间公司发生派息、送股、转增股本等情况，减持价格下限将按监管要求调整。
- 经本次权益分派调整后，相关股东减持价格下限为不低于16.34元/股。
该承诺的调整为市场提供了明确的减持底价，有助于稳定市场预期。
七、投资者须知与联系方式
- 如有疑问，投资者可在工作日通过润本股份证券部联系电话：020-38398399进行咨询。
八、投资者关注要点及潜在价格影响因素
- 本次高比例现金分红显示公司稳健盈利与良好现金流，或提振市场信心。
- 减持价格下限调整后，核心股东减持意愿与实际操作空间受限，短期内有助于平抑股价波动。
- 复杂的税务政策对不同投资者影响不一，需及时关注自身税负情况。
免责声明：本新闻解读仅供投资者参考，不构成任何投资建议或买卖依据。投资有风险，入市需谨慎。
English Version
Deep Dive into Runben Biotech 2025 Dividend Payout Implementation Announcement
1. Key Highlights
Runben Biotech Co., Ltd. (Stock Code: 603193, Stock Short Name: Runben Biotech) published its 2025 annual dividend implementation announcement on May 25, 2026. The payout is substantial and the detailed implementation and tax rules are highly relevant to investors.
2. Dividend Plan Details
- Dividend per Share: Based on the total share capital (404,593,314 shares) as of May 28, 2026 (after market close), a cash dividend of RMB 0.26 per share (pre-tax) will be distributed, totaling RMB 105,194,261.64 (pre-tax).
- No differentiated bonus or shares: This dividend does not involve differentiated dividend/share transfers.
3. Key Dates
| Share Type | Record Date | Last Trading Day | Ex-dividend Date | Dividend Payment Date |
|---|---|---|---|---|
| A shares | 2026/5/28 | – | 2026/5/29 | 2026/5/29 |
4. Distribution and Claim Process
- Unrestricted shares: Dividends will be paid via the Shanghai Clearing House system to registered shareholders.
- Investors who have completed designated trading can claim the cash dividend at their securities branch on payment day; those who haven’t need to complete the procedure first.
- Some major shareholders will receive dividends directly from the company, including Guangzhou Zhuofan Investment Holding Co., Ltd., Zhao Guiqin, etc.
5. Tax Policy Explanation (Crucial for Investors)
- Individual shareholders & securities funds:
- Holding period >1 year: Dividend income temporarily exempt from personal income tax; actual payout RMB 0.26 per share.
- Holding period ≤1 year: No tax withheld for now; actual payout RMB 0.26. When sold, tax is withheld according to the holding period—20% for ≤1 month, 10% for 1 month to 1 year.
- Restricted shares (individuals & funds): Pre-unlock, actual tax burden is 10%, after-tax RMB 0.234 per share; post-unlock taxed according to holding period.
- QFII/RQFII: 10% tax withheld; after-tax RMB 0.234 per share. Can apply for treaty benefits if eligible.
- Shanghai-Hong Kong Stock Connect: 10% tax withheld by company; after-tax RMB 0.234 per share.
- Other institutional & corporate shareholders: No withholding; must self-declare taxes. Payout is pre-tax RMB 0.26 per share.
These tax policies will directly affect actual returns. Investors should pay close attention to their own tax status and compliance.
6. Adjustment of Major Shareholder Sell-down Price Commitment (Highly Sensitive)
- Core shareholders, directors, and senior managers previously committed: Within two years after IPO lockup, no shares will be sold below IPO price, adjusted for dividends, bonus shares, etc. According to the latest adjustment, the sell-down price floor is no less than RMB 16.34 per share.
This adjustment sets a clear lower limit for major shareholder sell-downs, which helps stabilize market expectations and may influence share price volatility.
7. Investor Information & Contact
- For queries, investors can contact Runben Biotech’s securities department at 020-38398399 during weekdays.
8. Investor Takeaways & Potential Price Impact
- This high cash dividend signals strong profitability and healthy cash flow, likely to boost market confidence.
- Sell-down price floor adjustment restricts major shareholder selling and can act as a share price stabilizer in the short term.
- Complex tax rules will impact different investors differently; act promptly to optimize tax outcomes.
Disclaimer: This analysis is for reference only and does not constitute investment advice. Investing involves risk—proceed with caution.
